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Biochemistryc and Graduate Program in Neuroscience,d Western University, London, Ontario, Canada; Départment de Biochimie, Université de Montreal, Montreal,
Quebéc, Canadae

M

edulloblastomas (MEDs) and neuroblastomas (NBs) represent two of the most common childhood neoplasias of the
central and peripheral nervous systems (1, 2). MEDs arise from
progenitor cells in the cerebellum (3) while NBs arise from undifferentiated sympathoadrenal cells of neural crest origin (2, 4). In
general, the age of onset for both MEDs and NBs is an important
determinate of the final prognosis, with complete regression often
being reported in children under 1 year of age. In contrast, tumors
that arise in older children often become metastatic and highly
resistant to conventional therapies (5). Two markers, the expression of which correlate with positive prognosis in both MEDs and
NBs, are the closely related receptor tyrosine kinases (RTKs) TrkA
and TrkC (5, 6, 7). In contrast, expression of TrkB correlates with
enhanced drug resistance, MYCN expression, and angiogenesis
(5) and is a poor prognostic predictor of NBs, and it also facilitates
cell survival and proliferation in MEDs (8).
The relationship between Trk receptor expression and the final
prognostic outcome has been linked to the induction of cell death.
In many instances, in both primary as well as established MED,
NB, and glioblastoma (GB) cell lines, expression of either TrkA or
TrkC has been linked to the induction of either apoptosis or autophagy (1, 9–12). In contrast, we have shown that nerve growth
factor (NGF) treatment of MED Daoy cells that overexpress TrkA
(Daoy-TrkA) show a dramatic increase in uncontrolled macropinocytosis, causing catastrophic disintegration of cellular membrane integrity, which results in cell death (13). No evidence of
apoptosis or necrosis is observed, and although evidence of autophagy is present, small interfering RNA (siRNA)-mediated
knockdown of the key autophagy proteins, beclin and Atg5, does
not prevent cell death (13).
Macropinocytosis is an actin-dependent, clathrin-independent, endocytic process that can be triggered by external stimuli
and serves as a means for cells to take up large amounts of extracellular materials as nutrients (14, 15, 16). Under normal conditions, macropinocytosis can also facilitate receptor-mediated sig-
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naling pathways, the entry of viral and bacterial pathogens, and
cell motility (16) and is the mechanism by which macrophages
and dendritic cells internalize antigens and cellular debris (16, 17).
More recently, macropinocytosis has also been shown to facilitate
the uptake of amino acids in Ras-transformed pancreatic tumor
cells to sustain their uncontrolled proliferation (14). Macropinosomes are generated by the formation of cell surface lamellipodia that fold back on themselves, resulting in large endosomes,
which can be larger than 0.2 m in diameter (18). Under normal
physiological conditions, macropinosomes are either recycled
back to the cell surface, or they fuse with lysosomes to digest internalized nutrients (15, 16). By comparison, the macropinosomes generated in NGF-treated Daoy-TrkA cells internally
fuse, growing uncontrollably larger, and in turn fuse with lysosomes (13). The cells literally drink and eat themselves to death.
In addition to our observations in MEDs, hyperstimulation of
macropinocytosis has also been found to result in cell death in
some human GB cell lines as well as in other cancer cell lines
(19–22). Interestingly, overexpression of oncogenic Harvey-Ras
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Macropinocytosis is a normal cellular process by which cells internalize extracellular fluids and nutrients from their environment and is one strategy that Ras-transformed pancreatic cancer cells use to increase uptake of amino acids to meet the needs of
rapid growth. Paradoxically, in non-Ras transformed medulloblastoma brain tumors, we have shown that expression and activation of the receptor tyrosine kinase TrkA overactivates macropinocytosis, resulting in the catastrophic disintegration of the cell
membrane and in tumor cell death. The molecular basis of this uncontrolled form of macropinocytosis has not been previously
understood. Here, we demonstrate that the overactivation of macropinocytosis is caused by the simultaneous activation of two
TrkA-mediated pathways: (i) inhibition of RhoB via phosphorylation at Ser185 by casein kinase 1, which relieves actin stress fibers, and (ii) FRS2-scaffolded Src and H-Ras activation of RhoA, which stimulate actin reorganization and the formation of lamellipodia. Since catastrophic macropinocytosis results in brain tumor cell death, improved understanding of the mechanisms
involved will facilitate future efforts to reprogram tumors, even those resistant to apoptosis, to die.

(H-Ras), has been shown to drive cell death by macropinocytosis
in the GB cell line, U251 (13, 20), by a mechanism that is dependent upon activation of the GTPase Rac1 and the inactivation of
Arf6 (23).
Here, we characterize the signaling mechanisms that drive
TrkA-dependent cell death by macropinocytosis in Daoy cells. We
find that, similar to U251 cells, induction of macropinocytosisdependent cell death requires the activation of H-Ras; however,
unlike U251 cells, it does not depend on the activation of Rac1 or
Cdc42.
Moreover, we find that overexpression of constitutively active
(CA) H-Ras alone is sufficient to activate macropinocytosis-dependent cell death. While it may seem surprising that CA-H-Ras
can stimulate cell death in a brain tumor cell line, it is important to
note that activating mutations of either H-Ras, neuroblastomaRas (N-Ras), or Kirsten-Ras (K-Ras) have not been found in cancers of the brain (24, 25). In terms of understanding the mechanisms driving this process, we demonstrate the concomitant
requirement of several signaling pathways. First, we find that activation of Src is essential, which is known to precede activation of
H-Ras (26), and that this is mediated via the adapter protein FRS2
(fibroblast growth factor receptor substrate 2), not ShcA, which
competitively binds to the juxtamembrane phosphorylated tyrosine residue, pTyr490/499, on activated TrkA (27). Second, we
show that two Rho family GTPases, RhoA and RhoB, are the endpoint effectors and that they serve essential but opposite roles in
regulating macropinocytosis. Finally, we have identified an essential role for the serine/threonine kinase casein kinase 1 (CK1) in a
mechanism that involves the phosphorylation of RhoB at Ser185.
This single event inactivates RhoB (28), releasing actin stress fibers, and enables RhoA to reorganize actin into the lamellipodial
extensions required to generate macropinosomes.
MATERIALS AND METHODS
Antibodies and growth factors. The antibodies to ␤-actin and Arf6 were
from Sigma-Aldrich. Antibodies to Cdc42, FRS2, H-Ras, N-Ras, Rap1,
RhoB, and Sck (ShcB) were from Santa Cruz Biotechnology. Antibodies to
RhoA, phospho-Src (Tyr416), phosphor-Src (Tyr547), and anti-phosphoTrkA (Tyr490) were from Cell Signaling Technology. Antibodies to ShcA,
ShcC, and Rac1 were from BD Bioscience. The antibody to K-Ras was
from Abcam, and the antibody to v-src was from Calbiochem. Horseradish peroxidase (HRP)-coupled secondary antibodies (rabbit anti-mouse
and goat anti-rabbit antibodies) were from Jackson ImmunoResearch
Labs, Inc., and were used at final concentrations of 1:10,000. Antibodies
were used at working concentrations as follows: anti-␤-actin (1:10,000),
anti-phospho-TrkA (Tyr490) (1:2,000), phospho-Src (Tyr416) (1:5,000),
phospho-Src (Tyr547) (1:2,000), anti-ShcA (1:5,000), anti-ShcC (1:
10,000), anti-ShcB (1:1,000), anti-FRS2 (1:2,000), anti-v-src (1:1,000),
anti-glutathione S-transferase (anti-GST)–HRP (1:5,000), anti-Ras (1:
1,000), anti-Rac (1:1,000), anti-Cdc42 (1:5,000), anti-Arf6 (1:1,000), antiRhoA (1:1,000), anti-RhoB (1:500), and anti-Rap1 (1:1,000). Nerve
growth factor (NGF) was from Harlan Products for Bioscience.
Vectors and cloning. CA-Rac1 (Q61L) was generated by site-directed
mutagenesis using PfuTurbo (Stratagene). Human H-Ras cDNA was obtained by PCR amplification from human placenta cDNA and subcloned
into pEGFP-C1 (where EGFP is enhanced green fluorescent protein). CAH-Ras (G12V)-EGFP was generated using human CA-H-Ras as a template
by site-directed mutagenesis using Pfu Turbo. All other constructs were
provided by the following investigators: EGFP-tagged DN (T19L) and CA
(Q63L) RhoB from A. Richmond (Vanderbilt University School of Medicine, TN); EGFP-tagged DN (T66N) and CA (Q111L) Rab34 from T. Endo
(Chiba University, Chiba, Japan); EGFP-tagged CA (G12V) and DN

October 2016 Volume 36 Number 20

(T17N) Cdc42, DN (S17N) Rac, DN (K44A) dynamin 2, DN (T31N) Arf1,
yellow fluorescent protein (YFP)-tagged DN (N19L) RhoA, DN (S34N)
Rab5, DN (T22N) Rab7, and EGFP-tagged clathrin from S. Ferguson
(University of Ottawa, Ontario, Canada); EGFP-tagged DN (S17N) and
CA (G12V) Rap1b from P. Stork (Vollum Institute, OR); pYFP-tagged DN
(S147A) CtBP1/BARS from Alberto Luini (Institute of Protein Biochemistry, NRC, Naples, Italy); EGFP-tagged DN (T17N) and CA (Q61L) Arf6
from J. Donaldson (NIH, MD); constructs encoding the pleckstrin homology (PH) domains of phospholipase C␦ (PLC␦) and AKT fused with
EGFP as well as the Ras binding domain (RBD) cysteine-rich domain
(CRD) of c-Raf-1 fused with EGFP from T. Balla (NIH, MD); EGFPtagged cRaf-1 CRD (R89A) mutant from Y. Sako (RIKEN ASI, Japan);
EGFP-tagged DN-Src516 (residues 1 to 516) from N. Yamaguchi (Chiba
University, Japan); EGFP-RhoB (S185A) from A. Pradines (INSERM,
Toulouse, France), and the GFP-RhoA binding domain of rhotekin to
visualize active RhoA (GFP-rGBD) from W. Bement (Addgene 26740 and
26732). pGex vectors expressing GST fusions encoding binding domains
for specific GTPases were obtained from the following investigators: RBD
of c-Raf (Raf-RBD) from D. Shalloway (University of California, Berkeley, CA); Cdc42/Rac-interacting binding (CRIB) domain of p21-activated
kinase 1 (Pak1) from A. Hall (Memorial Sloan-Kettering Cancer Center,
NY); RBD of RalA (RalGDS-RBD) from P. Stork (Vollum Institute, OR);
Rho binding domain of rhotekin from A. Richmond (Vanderbilt University, TN); and the N-terminal GAT (NGAT) domain of the Golgi compartment-localized gamma ear-containing Arf-binding protein 3
(GGA3), which binds activated Arf6, from M. Park (McGill University,
Montreal, CA).
Cell culture and transfections. Daoy-TrkA cells were provided by V.
Lee (University of Pennsylvania, PA) and maintained in Dulbecco’s minimal Eagle medium (DMEM) supplemented with 10% fetal bovine serum,
100 g/ml gentamicin sulfate, and 100 g/ml G418. Daoy cells were
grown in the same medium without G418. Cells were routinely transfected with 4 to 10 g of plasmid or 20 nM siRNA using Lipofectamine
2000 (Life Technologies) or DreamFect Gold (OZ Biosciences) according
to the specifications of the manufacturer.
Small interfering RNAs. Validated or sequence-specific siRNAs were
generated and purchased from Life Technologies against the following
targets: (i) human H-Ras (validated stealth siRNA VHS40291), (ii) human FRS2 (sense, CUG GCU AUG ACA GUG AUG AAC GAA G; antisense, CUU CGU UCA UCA CUG UCA UAG CCA G), (iii) Src (sense,
AAC AAG AGC AAG CCC AAG GAU; antisense, AUC CUU GGG CUU
GCU CUU GUU) (29), (iv) human ShcA (silencer select 4390827; sense,
CUA CUU GGU UCG GUA CAU GGG; antisense, CAU GUA CCG AAC
CAA GUA GGA), (v) human Rac1 (sense, UUU GAC AGC ACC GAU
CUC UUU CGC C; antisense, GGC GAA AGA GAU CGG UGC UGU
CAA A), (vi) human Cdc42 (sense, UCC UUU CUU GCU UGU UGG
GAC UCA A; antisense, UUG AGU CCC AAC AAG CAA GAA AGG A)
(30), (vii) human RhoB (sense, CCG UCU UCG AGA ACU AUC UUU;
antisense, AGA UAG UUC UCG AAG ACG GUU), and (viii) a stealth
control (sense, GAG UCG ACC UAG UGU AAC ACC GAC A; antisense,
UGU CGG UGU UAC ACU AGG UCG ACU C). A Cy3-labeled negativecontrol siRNA (Life Technologies) was cotransfected with test siRNAs to
monitor transfection efficiency.
Inhibitor/dyes. Daoy-TrkA cells were pretreated with the following
inhibitors 1 h prior to NGF stimulation (100 ng/ml) unless otherwise
stated: 40 M concentration of the CK1 inhibitor (D4476; Calbiochem),
5 to 10 M concentration of the Rac1 inhibitor EHT1864 (Tocris Bioscience), and 2 g/ml of the Rho inhibitor CT04 (Cytoskeleton, Inc.). The
Src inhibitor PP2 (Sigma-Aldrich) was used at the concentrations indicated. Dimethyl sulfoxide (DMSO) was used as a negative control. Alexa
Fluor 546-dextran, Alex Fluor 488-dextran, and Alexa Fluor 546-transferrin (Life Technologies) were used at a final concentration of 5 g/ml
(dextran) or 50 g/ml (transferrin).
GTPase binding assays. Bacteria expressing pGex2T, pGex2T-PakCRIB, pGex-Raf1-RBD, pGex-RalGDS-RBD, pGex-Rhotekin-RBD, and
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nologies) overnight or with a 1.5 ratio of Dreamfect Gold in 100 l of
serum-free Opti-MEM for 4 h. Fresh medium was provided, and cells
were either left untreated or treated with NGF as indicated. To monitor
latex bead uptake, cells were plated on 35-mm glass-bottom dishes and
cotreated with 2 l per ml of medium with an aqueous suspension of
fluorescent red (excitation, 575 nm; emission 610 nm)-labeled latex beads
(0.5 m in diameter) (Sigma-Aldrich) and Alexa Fluor 488-dextran (5
g/ml; Life Technologies) or Alexa Fluor 546-transferrin (10 g/ml; Life
Technologies) and Alexa Fluor 488-dextran (5 g/ml; Life Technologies)
prior to stimulation with 100 ng/ml NGF. Cells were visualized and captured with a Zeiss 510 Meta laser scanning confocal microscope using a
63⫻ oil objective (optical section width of 0.7 m).
Trypan blue exclusion assay. NGF-dependent cell death in DaoyTrkA cells was quantified by trypan blue exclusion at 24 h following NGF
stimulation. Cells were trypsinized and diluted 1:4 with 0.4% trypan blue
solution, and the numbers of total cells and blue cells were counted by
phase-contrast microscopy on a hemacytometer. All experiments were
performed in triplicate.
Statistical analysis. All of the experiments were conducted at least
three times. One-way analysis of variance (ANOVA) with Tukey multiple
comparison tests was used to analyze the difference of means among each
group. A P value of ⬍0.05 is considered statistically significant.

RESULTS

TrkA generates large macropinosomes. To determine whether
TrkA-induced macropinocytosis is distinct from receptor-mediated endocytosis, we employed two reporters, namely, Alexa Fluor
546-transferrin as a probe for receptor-mediated endocytosis and
Alexa Fluor 488-dextran as a general tracer of fluid uptake via any
mechanism. In the absence of NGF, we find significant colocalization of Alexa Fluor 488-dextran and Alexa Fluor 546-transferrin
consistent with dextran being cointernalized with transferrin via
endocytosis; however, in the presence of NGF, the bulk of Alexa
Fluor 488-dextran (green) internalizes independent of Alexa
Fluor 546-transferrin (red) into large (0.5-m) macropinosomes
(Fig. 1A). We then investigated the initial size of the vacuoles
formed using Alexa Fluor 546-labeled latex beads and monitored
their colocalization with Alexa Fluor 488-dextran. We found that
cells could readily internalize 0.5-m Alexa Fluor 546-labeled latex beads in response to NGF and that this showed significant
colocalization with the Alexa Fluor 488-labeled dextran (Fig. 1B).
By comparison, cells were not able to internalize 1.0-m Alexa
Fluor 488-labeled latex beads (data not shown).
Phosphatidylinositol 4-phosphate 5-kinase (PIP5K) and
phosphatidylinositol 3-kinase (PI3 kinase) participate in TrkAinduced macropinosome formation. We then initiated a series of
experiments to characterize both the composition of the TrkAinduced macropinosome membranes as well as the signaling
mechanism(s) that regulates their growth. We first determined
whether TrkA-induced macropinosome membranes contain
components identified in either constitutive or stimulated macropinosomes described in the literature, specifically, phosphatidylinositol 4,5-bisphosphate (PIP2) and phosphatidylinositol
3,4,5-triphosphate (PIP3) (15). We used EGFP-tagged constructs
encoding the PH domain of AKT, which preferentially binds PIP3
and to a lesser extent PIP2, as well as the PH domain of phospholipase D which binds only PIP2 (31). Cells transfected with EGFP
alone showed diffuse green staining throughout the cell, and the
macropinosome ruffles were not clearly identified (Fig. 1C); however, we found that both EGFP-tagged PH domain constructs
were present within the macropinosome ruffles, indicating that
both PIP2 and PIP3 are components of the initial lamellipodia
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pGex-GGA3-NGAT were grown in 50 ml of Luria broth (LB) with 50
g/ml ampicillin for 16 h at 37°C and then added to 500 ml of LB with 50
g/ml ampicillin and grown to an optical density at 600 nm (OD600) of 0.8
to 1.0. Cultures were induced with isopropyl-␤-D-thiogalactopyranoside
(IPTG; 0.2 mg/ml) for 2 h at 37°C, centrifuged at 5,000 rpm for 10 min
(4°C), resuspended in 10 ml of 1⫻ phosphate-buffered saline (PBS), and
frozen at ⫺80°C. Pellets were resuspended in 20 ml of resuspension buffer
(25 mM Tris-Cl, pH 7.5, 5 mM EDTA, pH 8.0, 150 mM NaCl, 1 mM
phenylmethylsulfonyl fluoride [PMSF], 1 g/ml leupeptin). Cells expressing the Pak-CRIB domain were lysed by two passages through a
prechilled French press at 20,000 lb/in2. Triton X-100 was added to a final
concentration of 1%, and the sample was rotated for 30 min at 4°C. All
other GST fusions were resuspended as described above and lysed directly
by the addition of Triton X-100 to a final concentration of 1%. Samples
were centrifuged at 14,000 rpm for 10 min at 4°C. Washed glutathioneagarose (500 l) (Sigma-Aldrich) was added to the supernatant, and the
mixtures were incubated for 16 h at 4°C, followed by three washes with 10
ml of 1⫻ PBS and resuspended in 250 l of interaction buffer (20 mM
HEPES, 150 mM NaCl, 0.05% NP-40, 10% glycerol, 1 mM PMSF, 1 g/ml
leupeptin). To measure changes in GTP activation, Daoy-TrkA cells were
left untreated or stimulated with NGF (100 ng/ml) for 10 min, 6 h, 12 h,
and 24 h. Prior to lysis, cells were placed on ice, washed with ice-cold
phosphate-buffered saline (PBS), lysed in 500 l of interaction buffer
(containing 100 M GTP␥S, 10 g/ml aprotinin, 2 g/ml leupeptin, and
1 mM PMSF) for 2 min, and lysates were centrifuged at 10,000 rpm for 10
min at 4°C. Protein concentrations of lysates were determined with a
detergent-compatible (DC) protein assay kit (Bio-Rad), and the main
lysates were flash frozen in liquid nitrogen and stored at ⫺80°C until use.
Purified GST fusion proteins (approximately 30 g) were added to 500 to
1,000 g of unstimulated and NGF-stimulated Daoy-TrkA lysates and
incubated at 4°C for 16 h (1 h for RhoA). Samples were pelleted at 14,000
rpm at 4°C and washed twice with interaction buffer. Laemmli sample
buffer with 100 mM dithiothreitol (DTT) was added, and samples were
heated at 70°C for 10 min. Proteins were analyzed by 12% SDS-PAGE and
blotted with anti-GST–HRP (1:5,000), anti-H-Ras (1:1,000), anti-Rac1
(1:1,000), anti-Cdc42 (1:5,000), anti-Arf6 (1:1,000), anti-RhoB (1:500),
anti-RhoA (1:1,000), and anti-Rap1 (1:1,000) antibodies. Lysates from
each time point (25 l) were also assayed for changes in the expression of
each GTPase relative to ␤-actin as a control.
Immunoprecipitation and Western blotting. Daoy-TrkA cells were
stimulated with NGF (100 ng/ml), washed twice with ice-cold PBS containing 1 mM sodium orthovanadate, and lysed in NP-40 lysis buffer (1%
NP-40, 137 mM NaCl, 10% glycerol, 1 mM EDTA, 50 mM Tris-HCl, pH
8.0) containing 1 mM sodium orthovanadate, 10 mM NaF, 10 g/ml
aprotinin, 2 g/ml leupeptin, and 1 mM PMSF. Clarified supernatants
were collected by centrifugation, and lysates (500 g) were immunoprecipitated with an antibody to TrkA and GammaBind Plus Sepharose (Amersham Pharmacia Biotech). Immune complexes were collected by centrifugation after an overnight incubation at 4°C, washed, and resuspended
in SDS-PAGE sample buffer. Immunoprecipitated proteins or whole-cell
lysates (WCLs) were separated by SDS-PAGE, transferred to 0.2-mpore-size polyvinylidene difluoride (PVDF) membrane (Bio-Rad),
blocked for 1 h in 10% nonfat milk at room temperature, probed for the
protein of interest overnight at 4°C, and visualized using HRP-conjugated
secondary antibodies (1:10,000) with an Immun-Star WesternC chemiluminescence kit (Bio-Rad). To determine which of the three Shc and Ras
genes are expressed in Daoy-TrkA cells, 25 or 50 g of whole-cell lysates
from Daoy-TrkA, HeLa cells, E18 (brain), P3 (brain), or P20 mouse cortex
was separated by either 10 or 12% SDS-PAGE and analyzed as described
above.
Confocal microscopy. Daoy-TrkA cells were seeded (50,000 cells) and
cultured on 35-mm glass-bottomed dishes (MatTek Corporation) or
poly-D-lysine-coated coverslips. The next day, cells were transfected with
the appropriate expression plasmid (1 to 2 g) mixed with Lipofectamine
2000 (Life Technologies) in 100 l of serum-free Opti-MEM (Life Tech-
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FIG 1 NGF-induced macropinosomes cointernalize dextran with 0.5-m latex beads and contain both PIP2 and PIP3. Cells were cotreated with Alexa Fluor
546-transferrin and Alexa Fluor 488-dextran (A) or Alexa Fluor 488-dextran and 0.5-m Alexa Fluor 546-latex beads (10 ng) (B) or transfected with EGFP alone
or EGFP-tagged constructs encoding the PH domain of AKT (PIP3 tracer) (C), the PH domain of PLD (PIP2 tracer) (D), or EGFP-clathrin (E). Alexa Fluor
546-dextran was given as a fluid tracer, and cells were stimulated with 100 ng/ml NGF (24 h) and visualized by confocal microscopy. Scale bars, 10 m.

(Fig. 1C and D). In fact, some of the initial macropinosomes contained Alexa Fluor 546-dextran (arrows) used as a fluid tracer.
However, as the vacuoles internalized from the cell surface, both
PH-AKT and PH-phospholipase D (PLD) were lost from the
membrane, consistent with the fact that both PIP2 and PIP3 are
lost during endocytosis (15). Consistent with our observation that
NGF-dependent Alexa Fluor 488-dextran internalization was independent of receptor-mediated transferrin uptake (Fig. 1A), we
found that EGFP-tagged clathrin did not label TrkA-induced
macropinosomes (Fig. 1E).
TrkA stimulation causes activation of H-Ras and Rac. To define TrkA-dependent pathways that drive macropinocytosis, we
focused on molecules that serve roles in clathrin-independent endocytosis and macropinocytosis-dependent actin remodeling.
Collectively, these include PAK1, PI3 kinase, and Src (32), as well
as several GTPases, including H-Ras, Cdc42, Rac1, Rab5, Arf1,
Arf6, RhoA, and CtBP1/BARS (15, 16, 21, 33, 34, 35). With respect
to Trk signaling, TrkA has been shown to activate H-Ras, Rap-1,
Rac, and Cdc42 as well as to negatively regulate RhoA, depending
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on the cellular context (36–45). Thus, we first examined the NGFinduced activation kinetics of these GTPases using GST fusion
proteins that contain binding domains of effector proteins that
bind only the activated GTPases (PAK-1 for Rac and Cdc42, cRaf-1 for H-Ras, Ral GDS for Rap1, and GGA3 for Arf6). Rac1
showed low basal activity in unstimulated cells and was weakly
activated, as early as 10 min, in response to NGF (Fig. 2A). By
comparison, there also were basal levels of H-Ras activation in
unstimulated cells; however, in response to NGF, we observed a
larger increase in H-Ras activation as early as 10 min, and this
activation peaked at 6 h and remained elevated for up to about
12 h. Endogenous levels of H-Ras expression also remained constant during the 24-h period (Fig. 2B). When we directly compared activation levels of H-Ras relative to those of Rac, we found
that Ras activation ranges from 3- to 7-fold while activation of Rac
was less than 1-fold (Fig. 2C). By comparison, we found basal
levels of Rap1, Cdc42, and Arf6 activation in unstimulated cells,
and while Arf6 has never been shown to be activated by TrkA, it is
activated downstream of some RTKs such as the Met (46) and
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FIG 2 NGF-stimulated Daoy-TrkA cells activate both Rac and H-Ras. Daoy-TrkA cells were stimulated with 100 ng/ml NGF, and lysates were harvested at 10
min, 6 h, 12 h, and 24 h. (A and B) Lysates were assayed for activation of H-Ras and Rac using GST fusion proteins that bind only active Rac1 (Pak-1-CRIB) (A)
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muscle-specific kinase (MuSK) receptors (47), and it is involved
in some forms of clathrin-independent endocytosis (15, 48).
However, NGF did not stimulate any obvious change in the activation of Rap1, Cdc42, or Arf6 in Daoy-TrkA cells during the 24-h
period of stimulation (see Fig. S1 in the supplemental material).
To complement the GTPase activation assays, we next determined whether dominant negative (DN) GTPase expression
affected NGF-dependent macropinocytosis and found that DNH-Ras and DN-Rab5 blocked NGF-induced macropinosomes,
DN-Arf6 reduced the macropinosome size, while DN-Rap1b,
-Rab7, -Rac1, -Arf1, -Rab34, -Dyn-2, -Cdc42, and -CtBP1/BARS
had no effect (Fig. 3A). While NGF did not affect basal levels of
Arf6 activation in Daoy-TrkA cells, the observation that DN-Arf6
reduced macropinosome size is consistent with the literature in
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that it traps activated H-Ras in recycling endosomes (49) and with
our observation that DN-Arf6 generated small macropinosomes
containing Alexa Fluor 546-dextran (Fig. 3A). The ability of DNRab5 to block NGF-induced macropinosomes is consistent with
its known roles in mediating the early fusion of endosomes (15)
and H-Ras-induced macropinosomes (49). With respect to DNRac1, as stated earlier, CA-Ras-dependent activation of macropinocytosis in U251 cells increased the pool of active Rac1 (21, 23),
which is known to serve a role in membrane ruffling and the
formation of lamellipodia (50, 51, 52). In contrast, we found that
the levels of NGF-activated Rac1 in Daoy-TrkA cells were relatively low by 12 to 24 h (Fig. 2C), consistent with the fact that
DN-Rac could not prevent TrkA-dependent macropinocytosis
and that pretreatment of cells with the Rac-specific inhibitor
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FIG 3 Expression of DN-H-Ras and Rab5 blocks and Arf6 reduces the size of NGF-induced macropinosomes. (A) EGFP-tagged DN GTPases (H-Ras, Arf6,
Rab5, Rap1b, Rab7, Rac1, Arf1, Rab34, Dyn2, Cdc42, and CtBP1/BARS) were transfected into Daoy-TrkA cells and assayed for changes in both NGF-induced
macropinosomes and the uptake of Alexa Fluor 546-dextran relative to cells transfected with EGFP at 24 h. Scale bars, 10 m. (B) The Rac-specific inhibitor
EHT1864 (10 M) was assayed for changes in both NGF-induced vacuole formation at 24 h (phase-contrast microscopy) and changes in the activation of Rac
at 6 h in a pulldown assay. Asterisks indicate a statistically significant (P ⬍ 0.05) increase in Rac activation at 6 h, relative to the level in unstimulated cells, as well
as a significant decrease in activity in the presence of EHT1864, as determined using one-way ANOVA and a Tukey posttest.

EHT1864 (5 M) did not block NGF-induced macropinosome
formation despite its ability to block Rac1 activation at 6 h
(Fig. 3B).
In a complementary approach, we then evaluated whether
overexpression of constitutively active (CA) GTPases could drive
NGF-independent macropinocytosis in Daoy cells (Fig. 4A). We
found that overexpression of both CA-Ras and CA-Arf6 caused
the generation of large vacuoles, consistent with macropinocytosis, and that CA-Rac1 generates small vacuoles while CA-Cdc42,
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CA-Rab34, and CA-Rap1b did not generate any. Since NGF did
not stimulate any change in Arf6 activation, the CA-Arf6 vacuoles
likely represent trapped vacuoles that cannot recycle back up to
the membrane and subsequently fuse (15). Collectively, these observations suggest that H-Ras is the primary GTPase driving
TrkA-dependent macropinosome formation. To test this hypothesis further, we addressed whether CA-Ras-induced macropinosomes could be blocked by the CK1-specific inhibitor D4476
(53), which we previously found to block TrkA-induced macropi-
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FIG 4 CA-Ras mimics NGF-induced macropinocytosis in Daoy-TrkA cells. (A) EGFP-tagged CA-Ras and CA-Arf6, but not CA-Rac1, Rab34, Cdc42, or Rap1b,
induce NGF-independent macropinocytosis and Alexa Fluor 546-dextran uptake comparable to levels in cells transfected with EGFP and NGF stimulated (24 h).
(B) Macropinosomes induced by CA-Ras-EGFP but not by CA-Arf6-EGFP are blocked by the CK1 inhibitor D4476. (C) CA-Arf6-EGFP-induced macropinosomes contain both PIP3 (PH-AKT-mCherry) and PIP2 (PH-PLD-mCherry). (D) The majority of CA-Ras-EGFP-induced macropinosomes do not contain
PIP3 (PH-AKT-mCherry) and/or PIP2 (PH-PLD-mCherry) (white arrows). (E) EGFP-tagged RBD of c-Raf-1 localizes active Ras in the initial lamellipodia and
the macropinosomes as well as in large, fused vacuoles in the presence of NGF. (F) The EGFP-tagged cRaf-1 CRD (R89A) mutant, which cannot bind active Ras,
is diffusely found throughout the cytosol in the presence of NGF. Scale bars, 10 m.

nocytosis (13). As expected, we found that CA-Ras-induced but
not CA-Arf6-induced macropinosomes could be completely
blocked by D4476 (Fig. 4B). We further examined the phospholipid composition (PIP2 and PIP3) of CA-Arf6- and CA-Ras-induced macropinosomes compared to that of macropinosomes induced by TrkA by coexpressing EGFP-CA-Arf6 and CA-Ras with
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red fluorescent protein (RFP)-fused PH domains of AKT and
PLD. We found that CA-Arf6 vacuoles contain both PIP2/PIP3
(Fig. 4C), consistent with previous reports showing that unless
Arf6 is inactivated shortly after the initial stage of membrane internalization and PIP2 is lost, the vacuoles are trapped and become
progressively larger as they fuse (54). In contrast, we found that
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FIG 5 siRNA-mediated knockdown of H-Ras but neither Cdc42 nor Rac1 blocks NGF-induced macropinosomes. (A) Daoy-TrkA cells were transfected with

while the initial CA-Ras-induced ruffles contained PIP3, based on
the costaining with EGFP-PH-AKT (Fig. 4D, yellow arrows), the
internalized macropinosomes did not (Fig. 4D, white arrows). By
comparison, while all of the CA-Arf6-induced macropinosomes
still contained PIP2, only a few of the CA-Ras-induced macropinosomes contained PIP2 (Fig. 4D, white arrows). These observations are consistent with the lack of both AKT and PLD being
localized to the large internal TrkA-induced macropinosomes
(Fig. 1C and D) and further support the model that H-Ras is the
primary GTPase driving this process. Consistent with this logic,
the EGFP-tagged Ras binding domain (RBD) and cysteine-rich
domain (CRD) of the effector protein c-Raf-1 labeled both the
initial membrane ruffles as well as the enlarged vacuolar membranes (Fig. 4E, arrows). By comparison, an EGFP-tagged c-Raf-1
RBD-CRD mutant (R89A), which can no longer bind activated
H-Ras, was diffusely distributed in the cell (Fig. 4F) (55).
Knockdown of H-Ras prevents TrkA-induced macropinocytosis. To control against potential off-target effects generated by
overexpressing DN constructs, we utilized siRNAs to deplete specific GTPases and assayed changes in NGF-induced macropinocytosis. Transfection of siRNAs for both Cdc42 and Rac1 effectively
decreased their expression by 24 h relative to control siRNAs (Fig.
5A). However, when Daoy-TrkA cells were cotransfected with
both siRNAs, along with a Cy3-labeled control siRNA to identify
transfected cells, there was no apparent decrease in the size of the
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NGF-induced Alexa Fluor 488-dextran-containing vacuoles relative to sizes in cells transfected with a control siRNA (Fig. 5B). For
Ras, we first determined which of the three Ras genes (Harvey [H],
Kirsten [K], and/or neuroblastoma [N]) are expressed in DaoyTrkA cells and found high levels of H-Ras and K-Ras and low
levels of N-Ras (Fig. 5C). Given our overexpression studies with
CA and DN-H-Ras, we first determined how changes in H-Ras
expression alone would affect NGF-induced macropinosomes.
Using an siRNA specific to H-Ras, we found that it effectively
reduced endogenous expression of H-Ras (Fig. 5D) as well as the
size of NGF-induced vacuoles in Cy3 (red)-positive cotransfected
cells (Fig. 5E) relative to expression in cells transfected with siRNA
controls.
The FRS2 adapter, not ShcA, is essential to TrkA-induced
macropinosome formation. NGF activation of TrkA results in
receptor dimerization, phosphorylation of the activation loop
tyrosines, Tyr683/Tyr684, and subsequent phosphorylation of
Tyr490/499 in the juxtamembrane region. This enables competitive
binding between the Shc and FRS2 adapters to pTyr490 (27), and
since both Shc and FRS2 are able to activate H-Ras (Fig. 6A), we
determined which adapter is essential to this process. The Shc
family of adapters includes four members (ShcA, -B, -C, and -D)
(56). ShcA is highly expressed during embryogenesis and is expressed only in progenitor cells in the mature brain while ShcB/
ShcC are primarily expressed after birth, and ShcD is primarily
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siRNAs against Cdc42, Rac1, and a stealth control, and changes in protein expression were assayed by Western blotting at 48 h. (B) Daoy-TrkA cells were
cotransfected with a Cy3 (red) control siRNA and either a nonspecific siRNA (LC3) or siRNAs against both Cdc42 and Rac1. Cells were either left unstimulated
or treated with NGF, and changes in Alexa Fluor 488-dextran uptake were examined in Cy3-positive cells at 24 h. (C) Lysates from Daoy-TrkA cells were
examined to determine if they express one or all three Ras isoforms relative to expression in HeLa cell lysates as a control. (D) siRNA to H-Ras effectively reduce
H-Ras expression. (E) Daoy-TrkA cells were cotransfected with a Cy3 (red) control siRNA and either a nonspecific siRNA (LC3) or the H-Ras siRNA. Cells were
either left unstimulated or treated with NGF, and changes in Alexa Fluor 488-dextran uptake were examined in Cy3-positive cells at 24 h. Scale bars, 10 m.
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FIG 6 Binding of FRS2 but not ShcA to the phosphorylated juxtamembrane
tyrosine residue Tyr490 is essential to H-Ras activation by TrkA. (A) Schematic
showing that FRS2 and Shc bind competitively to pTyr490 following TrkA
activation. (B) Daoy-TrkA cells express ShcA but not ShcB or ShcC. siRNAs for
both human ShcA and FRS2 effectively reduce expression of their respective
targets in transfected Daoy-TrkA cells relative to the siRNA control. (C) DaoyTrkA cells were cotransfected with a Cy3 control siRNA and either a nonspecific siRNA (LC3) or the siRNA against ShcA or FRS2. Cells were either left
unstimulated or treated with NGF, and changes in Alexa Fluor 488-dextran
uptake were examined in Cy3-positive cells at 24 h. Scale bars, 10 m.

expressed outside the nervous system. We first determined which
Shc adapters were expressed in Daoy-TrkA cells compared to expression in lysates prepared from E18, P3, and P20 mouse cortices.
We found that Daoy-TrkA cells express only ShcA (Fig. 6B). Then
we assayed FRS2/ShcA siRNAs for loss of expression in transfected
Daoy-TrkA cells and found that both siRNAs effectively reduced
expression of their target proteins relative to a scrambled siRNA
control (Fig. 6B). Daoy-TrkA cells were then cotransfected with
ShcA/FRS2 siRNAs, along with a Cy3-labeled siRNA control, and
Cy3-positive cells were examined for changes in Alexa Fluor 488dextran uptake relative to that in cells transfected with a control
siRNA (LC3). Accordingly, we found that loss of FRS2 but not
ShcA effectively reduced the size of NGF-induced macropinosomes, resulting in macropinosomes comparable to those observed in unstimulated cells (Fig. 6C).
Src kinase is essential to NGF-induced macropinosome formation. The soluble tyrosine kinase, Src, is another candidate
signaling molecule that has been shown to be involved in mem-
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brane ruffling and macropinocytosis in different cellular contexts
(32, 57, 58). Although the molecular mechanisms involved in Srcmediated macropinocytosis have not been fully elaborated, many
of the pathways involve several downstream effectors such as PI3
kinase and phospholipase C as well as phospholipase D (15). Importantly, Src is known to be involved in TrkA-dependent signaling. Specifically, Src activation precedes the activation of H-Ras,
and it is recruited into TrkA signaling via FRS2 (Fig. 7A) (26, 27,
59). In our initial studies to investigate whether Src was involved
in NGF-induced macropinocytosis, we determined whether the
Src inhibitor, PP2, affected the process. Interestingly, we found
that 7.5 M PP2 effectively reduced macropinocytosis to levels
observed with vehicle alone (Fig. 7B) and that this concentration
did not affect TrkA kinase activity (Fig. 7C). While higher concentrations of PP2 also blocked cell death, they impeded NGF-induced phosphorylation of the juxtamembrane pTyr490 residue
(Fig. 7C). Activation of Src involves the dephosphorylation of the
self-inhibitory carboxyl-terminal tyrosine residue, Y527, and phosphorylation of Y416 which resides in the activation loop (60, 61,
62). When we examined the kinetics of Src phosphorylation in
response to NGF in Daoy-TrkA cells, we observed a significant
increase in the amount of phosphorylation at Y416 by 6 h, which
subsequently decayed over time (Fig. 7D), with little change in the
phosphorylation state of Y527 (data not shown). Cotreatment with
the CK1 inhibitor, D4476, did not affect the kinetics of Src activation (Fig. 7D, right panel), indicating that CK1 activation is either
independent or downstream of Src. We then used siRNAs to address the role of Src expression/activation on NGF-induced macropinocytosis. An Src siRNA effectively reduced Src expression by
24 h, and this remained reduced up to 72 h posttransfection (Fig.
7E). Moreover, we found that cells cotransfected with Src siRNA
plus a Cy3-labeled control siRNA showed a large reduction in the
internalization of Alexa Fluor 488-dextran compared to that in
cells transfected with control siRNAs and, in fact, internalized
Alexa Fluor 488-dextran to levels similar to those in unstimulated
cells (Fig. 7F). Finally, we expressed EGFP-tagged wild-type (WT)
Src, as well as a DN-Src mutant (residues 1 to 516) (32), in DaoyTrkA cells and determined how their expression affected NGFinduced macropinocytosis. The results demonstrate that overexpression of WT Src does localize to large macropinosomes in
NGF-stimulated cells (Fig. 7G). In contrast, overexpression of
DN-Src-GFP effectively blocks NGF-induced macropinosome
formation (Fig. 7G).
Casein kinase 1 phosphorylation and inactivation of RhoB
facilitate macropinocytosis. We next addressed the role of RhoB,
another member of the Rho family of small GTPases which also
includes RhoA and RhoC in macropinocytosis (63). RhoB is involved in a variety of cellular functions, including the organization
and maintenance of actin stress fibers (64). Thus, we first analyzed
cells for NGF-dependent changes in the activation of RhoB using
a GST fusion construct encoding the Rho binding domain of the
effector protein rhotekin. In contrast to all the other GTPases
tested (Fig. 2; see also Fig. S1 in the supplemental material), we
found a steady decrease in both the activation and expression levels of RhoB in response to NGF such that by 12 h, the amount of
active RhoB was approximately half that observed at 6 h (Fig. 8A).
In fact, no active RhoB was observed by 24 h though its levels of
expression remained constant between 12 and 24 h (Fig. 8A). We
then addressed whether inactivation of RhoB was essential to
macropinosome formation and found that expression of CA-
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via FRS2, and this facilitates activation of H-Ras. (B) Daoy-TrkA cells were treated with PP2 or DMSO (1 h) prior to addition of NGF and incubated for an
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Daoy-TrkA cells were either left untreated or pretreated with D4476 (1 h) prior to NGF stimulation. Lysates were analyzed for changes in the phosphorylation
status of Src (Y416) relative to total levels of Src and ␤-actin. (E) Daoy-TrkA cells were transfected with an Src siRNA or an Src scramble control for 24 h (left panel)
or up to 72 h (right panel), and changes in Src expression were determined by Western blotting relative to the level of ␤-actin. (F) Daoy-TrkA cells were
cotransfected with a Cy3 control siRNA and either a scramble siRNA or the Src siRNA. Cells were either left unstimulated or treated with NGF, and changes in
Alexa Fluor 488-dextran uptake were examined in Cy3-positive cells at 24 h. (G) Daoy-TrkA cells were transfected with EGFP-tagged WT or DN-Src and left
untreated or stimulated with NGF and Alexa Fluor 546-dextran for 24 h prior to examining changes in macropinocytosis. Scale bars, 10 m.

RhoB (Q63L) and the maintenance of actin stress fibers effectively
blocked NGF-induced macropinocytosis (Fig. 8B).
Previously, we showed that the CK1 inhibitor D4476 completely blocked NGF-induced macropinocytosis in Daoy-TrkA
cells although the mechanism was not initially clear (13). However, Tillement et al. demonstrated that RhoB, but neither RhoA
nor RhoC, is a direct target of CK1␦ kinase activity in vitro (28).
Specifically, they demonstrated that RhoB is phosphorylated at
Ser185, and this results in the inactivation of RhoB (28). Thus, we
considered the possibility that the failure to inactivate RhoB and
the maintenance of actin stress fibers underscore the inhibitory
action of D4476. To address this, we examined how expression of
an RhoB S185A mutant affects NGF-induced macropinocytosis. As
this mutant is incapable of being phosphorylated at Ser185, it
should exert a similar effect as CA-RhoB (Q63L) and block NGF-
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induced macropinosome formation. Consistent with this logic,
we found that expression of the RhoB (S185A) mutant did, in fact,
completely block NGF-induced macropinocytosis (Fig. 8B). To
complement these studies, we reduced RhoB expression by RNA
siRNA transfection and observed enhanced macropinocytosis in
response to NGF, indicating that loss of RhoB-dependent stress
fibers are essential (Fig. 8C).
RhoA activation is essential to NGF-induced macropinosome formation. We have demonstrated that the primary
GTPase driving NGF-induced macropinocytosis in Daoy-TrkA
cells is H-Ras (Fig. 2 to 5). However, activation of H-Ras itself does
not directly affect F-actin reorganization. Thus, we considered
whether activation of RhoA, which is known to directly affect
F-actin reorganization, was activated by NGF in Daoy-TrkA cells,
whether it was localized to the macropinosome membranes, and
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FIG 7 Src activation, via FRS2, is essential to NGF-dependent macropinocytosis and cell death. (A) Schematic showing that Src is recruited into TrkA signaling
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reorganization (Fig. 9B). To confirm that RhoA activation is essential to NGF-induced macropinocytosis, we transfected DaoyTrkA cells with YFP-tagged DN-RhoA (T19N) and observed that it
effectively blocked NGF-induced uptake of Alexa Fluor 546-dextran (Fig. 9C). Moreover, NGF-induced macropinosomes were
effectively blocked by the Rho inhibitor CT04 (Fig. 9D). Collectively, these data confirmed that RhoA is the final GTPase regulating actin reorganization and macropinosome formation in response to NGF stimulation of Daoy-TrkA cells.
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FIG 8 RhoB maintains actin stress fibers and must be inactivated via CK1dependent phosphorylation at Ser185 to enable NGF-induced macropinocytosis. (A) Daoy-TrkA cells were stimulated with NGF, and lysates were harvested
at 10 min, 6 h, 12 h, and 24 h and assayed for activation of RhoB using GSTrhotekin versus GST alone. Pulldown products and WCLs were analyzed on
12% SDS gels, and blots were probed with the indicated antibodies. WCLs
were also assayed for changes in expression of RhoB, relative to the ␤-actin
level, at each time point. (B) Daoy-TrkA cells were transfected with EGFP,
EGFP-tagged CA-RhoB (Q63L), and the EGFP-tagged site-directed RhoB mutant (S185A). Cells were stimulated with NGF, and Alexa Fluor 546-dextran
was added for 24 h before changes in macropinocytosis were examined. (C)
Daoy-TrkA cells were transfected with control or RhoB siRNA, and changes in
RhoB expression were examined by Western blotting at 24 h. (D) Cells were
cotransfected with a Cy3 control siRNA and either a control siRNA or the
RhoB siRNA. Cells were treated with NGF, and Alexa Fluor 488-dextran uptake was examined in Cy3-positive cells at 24 h. Scale bars, 10 m.

whether it was essential to drive macropinocytosis. In this respect,
RhoA activation has been shown to be associated with both neurite/dendritic extension and retraction in the nervous system (40,
65–69). We examined the kinetics of NGF-induced activation of
RhoA in Daoy-TrkA cells using a GST fusion protein containing
the Rho binding domain of rhotekin and observed RhoA activation as early as 10 min in response to NGF and peak activation at
6 h, and while the abundance of RhoA decreased by 12 to 24 h, the
remaining molecules were still active (Fig. 9A). Next, we used a
GFP-tagged reporter construct to visualize active RhoA (GFPrGBD) and found that RhoA is diffusely distributed within the
cytoplasm of unstimulated cells; however, following NGF stimulation, RhoA localized to the lamellipodia that initiate macropinocytosis, suggesting that it is the final GTPase stimulating F-actin
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We previously demonstrated that TrkA-expressing Daoy cells undergo NGF-dependent macropinocytosis, resulting in cell death
(13). Here, we have characterized the essential signaling cascade
that drives this process. Specifically, it involves the recruitment of
the FRS2 adaptor to activated TrkA and the subsequent activation
of Src, H-Ras, and RhoA and the CK1-dependent inactivation of
RhoB (Fig. 10). We found that macropinosomes are generated
independently of receptor-mediated internalization, do not contain clathrin, and can be as large as 0.5 m in size (Fig. 1). NGFdependent cell death in Daoy-TrkA cells was strikingly similar to
that observed in the GB cell line U251 following expression of
activated H-Ras (20, 21, 23). Similar to findings in U251 cells,
macropinocytosis in Daoy-TrkA cells is also dependent on the
activation of H-Ras. Specifically, expression of DN-H-Ras (Fig. 3)
and/or H-Ras siRNAs (Fig. 5D and E) completely blocked NGFinduced macropinocytosis. Conversely, macropinocytosis was induced in the absence of NGF by expression of CA-H-Ras (Fig. 4A),
and CA-H-Ras-induced macropinosomes could be blocked with
the CK1 inhibitor D4476 (Fig. 4B) that blocks NGF-induced macropinosomes (13). Finally, a construct encoding the Ras binding
domain of c-Raf-1 (RBD-CRD) clearly demonstrated that active
H-Ras was localized to the macropinosome membranes (Fig. 4E)
in contrast to the diffuse staining throughout the cytosol observed
with the EGFP-tagged c-Raf-1 RBD-CRD mutant (R89A) that cannot bind activated H-Ras (Fig. 4F) (55). Collectively, these data all
support the conclusion that H-Ras is the primary TrkA-coupled
GTPase driving macropinocytosis. While H-Ras could be activated, via either Shc or FRS2, which competes for receptor binding
following phosphorylation of the juxtamembrane tyrosine residue
Y490 on TrkA (27) (Fig. 10), our studies demonstrate that FRS2 is
the TrkA-dependent adapter essential to the process. Specifically,
loss of FRS2 but not ShcA expression prevents NGF-induced macropinocytosis (Fig. 6). While activation of H-Ras is commonly
associated with tumor cell growth and while many carcinomas
arise as a result of mutations in H-Ras, it is important to note that
activated H-Ras has never been reported as a cancer-causing oncogene in human brain tumors (24, 25). H-Ras has been shown to
have a diversity of roles in different cell types, including inducing
macropinocytosis to facilitate nutrient uptake in pancreatic tumors (14), in addition to its well-known roles in regulating cell
survival (70), senescence (71), and cell death (72). As described
earlier, H-Ras has been shown to stimulate macropinocytosis in
U251 cells via activation of Rac1 (23), and expression of CA-Rac1
can itself stimulate macropinocytosis and cell death (21). This is in
contrast to our observations that expression of CA-Rac1 had no
effect on macropinosome formation and that the expression of
DN-Rac1 and/or depletion of endogenous Rac1 by siRNA did not
affect NGF-induced macropinocytosis. Moreover, while NGF induced a rapid increase in activated Rac1 that was sustained up to
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approximately 12 h, the increase in activation was less than 1-fold
compared to the 3- to 7-fold increase in H-Ras activation during
the same time period (Fig. 2C). While Rac1 is rapidly activated in
response to NGF in PC12 cells and while it is necessary for Rho
inactivation and the release of stress fibers to facilitate neurite
outgrowth (44), we found that Rac1 activation was not essential
for NGF-dependent macropinocytosis in Daoy-TrkA cells. In fact,
the Rac-specific inhibitor EHT1864 had no effect on NGF-induced macropinocytosis, despite effectively blocking Rac activity
(Fig. 3B).
Another small GTPase implicated in macropinocytosis and
modulating actin dynamics and the endosomal recycling required
for some types of clathrin-dependent and clathrin-independent
endocytosis is Arf6 (15, 48, 73). Arf6 resides at the plasma membrane and when activated stimulates the accumulation of PIP2
at the membrane through activation of phosphatidylinositol
4-phosphate 5 kinase (PIP5K) and phospholipase D (PLD) (54, 74,
75), resulting in changes in the actin cytoskeleton (76). Following
internalization of the endosome or macropinosome, Arf6 is inactivated, and PIP2 is lost from the endosomal membrane (54) to be
replaced by PIP3 (49) generated by PI3 kinase (77). Under normal
conditions where the macropinosome matures and is then recycled back up to the cell membrane, activation of Arf6 is again
required for this final step and membrane fusion (54, 78). In U251
cells, the resting activity of Arf6 is high but drops significantly
upon stimulation of macropinocytosis (23). In contrast to these
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results, we observed no change in the activation levels of Arf6 in
NGF-stimulated Daoy-TrkA cells.
As has been observed in other cells (49, 54), expression of CAArf6 induced massive vacuolization similar to that observed with
CA-H-Ras in Daoy-TrkA cells. However, the phosphatidylinositide composition of the CA-Arf6-induced macropinosomes is different from that induced by both NGF (Fig. 1) and CA-H-Ras
(Fig. 4) in that CA-Arf6-induced macropinosomes result from the
continual fusion of primary vacuoles due to the continued activation of PIP5K and PLD (15, 54) and, as such, they are enriched in
PIP2 and PIP3 (15, 48, 54).
Many of the proteins involved in macropinocytosis are downstream effectors of the nonreceptor tyrosine kinase Src. In fact,
expression of CA-Src can induce the formation of membrane ruffles and macropinosomes in various cell types, including COS-7,
HeLa, MDCK, and mouse embryonic fibroblast (MEFs) cells (32,
58, 79), and also induces rapid loss of actin stress fibers in MEFs
(80). In addition, active Src associates with macropinosomes and
remains associated through maturation up to fusion with lysosomes (32). We found that inhibition of Src by PP2 (7.5 m)
resulted in a reduction of macropinocytotic cell death in NGFtreated Daoy-TrkA cells, comparable to control levels, without
affecting TrkA phosphorylation (Fig. 7B and C). Similarly,
siRNA-mediated knockdown of Src led to a reduction in vacuole
formation in the presence of NGF, comparable to the level in
controls (Fig. 7E and F). In fact, overexpressing WT Src led to
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FIG 9 RhoA activation drives lamellipodium formation and is essential to NGF-induced macropinocytosis in Daoy-TrkA cells. (A) Daoy-TrkA cells were
stimulated with NGF, and lysates were harvested at 10 min, 6 h, 12 h, and 24 h and assayed for activation of RhoA using GST-rhotekin versus GST alone. Pulldown
products and WCLs were analyzed on 12% SDS gels, and blots were probed with the indicated antibodies. WCLs were also assayed for changes in expression of
RhoA, relative to ␤-actin levels, at each time point. (B) Daoy-TrkA cells were transfected with an EGFP-tagged reporter construct encoding the RhoA binding
domain of rhotekin to visualize active RhoA (GFP-rGBD). Cells were examined by confocal microscopy in the absence or presence of NGF stimulation at 24 h.
(C) Daoy-TrkA cells were transfected with YFP-tagged DN RhoA (T19N), treated with Alexa Fluor 546-dextran, stimulated with NGF, and visualized by confocal
microscopy at 24 h. (D) Daoy-TrkA cells were treated with the Rho inhibitor CT04 (2 g/ml) for 1 h prior to stimulation of cells with NGF for 4 h. Cells were
visualized for macropinosomes by phase-contrast microscopy. Scale bars, 10 m.
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FIG 10 Schematic of TrkA-dependent signaling pathways that drive
macropinocytosis.

larger NGF-induced macropinosomes in Daoy-TrkA cells, and
Src was clearly localized on the internalized vacuoles, while expression of a DN mutant effectively blocked NGF-dependent
macropinosomes (Fig. 7G). Src activation precedes the activation
of H-Ras, is necessary for the sustained activation of extracellular
signal-regulated kinase 1 and 2 (Erk1/2) essential to neurite outgrowth in PC12 cells (81, 82, 83), and is recruited into TrkA signaling via FRS2 (27) (Fig. 10).
The final steps in driving macropinocytosis requires membrane ruffling and lamellipodium formation that are dependent
upon the relaxation of actin stress fibers, which enables actin to be
remodeled (15, 16). Members of the Rho family of GTPases, in
particular, RhoA, -B, and -C, have been shown to play important
roles in the organization and maintenance of actin stress fibers
(84). Our data indicate that relaxation of actin stress fibers, by
CK1-dependent phosphorylation and inactivation of RhoB at residue Ser185, is an essential initial requirement in the induction of
macropinocytosis. How TrkA regulates the constitutive kinase activity of CK1 (85) and drives the phosphorylation of RhoB, downstream of H-Ras, remains to be clarified. In contrast, we found
that activation of the related Rho family GTPase RhoA is essential
to stimulate the actin reorganization and lamellipodial formation
required to generate macropinosomes (Fig. 10). While RhoA has
classically been thought to regulate only stress fiber formation,
using fluorescent resonance energy transfer (FRET)-based report-
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ers, Kurokawa and Matsuda demonstrated that RhoA is also
highly activated in membrane ruffles and nascent lamellipodia in
multiple cell lines in response to different stimuli (86). Using a
GST fusion protein containing the Rho binding domain of rhotekin, we found RhoA highly activated in response to NGF, with
peak activation at 6 h and lower levels of activation by 12 to 24 h
(Fig. 9A). By using a reporter construct encoding the Rho binding
domain of rhotekin to visualize active RhoA (GFP-rGBD), we
found that active RhoA was diffusely distributed within the cytosol of unstimulated Daoy-TrkA cells, but in response to NGF,
RhoA localized to the membrane ruffles and lamellipodia (Fig. 9B,
arrows). Moreover, we found that expressing YFP-tagged DNRhoA (T19N) (Fig. 9C) as well treating Daoy-TrkA cells with the
Rho inhibitor CT04 (Fig. 9D) effectively blocked NGF-induced
macropinocytosis.
In summary, we have shown that macropinocytosis in DaoyTrkA cells can be stimulated in the absence of NGF by expression
of a CA mutant of H-Ras (G12V). In addition, NGF-induced macropinocytosis is prevented in cells expressing a DN-H-Ras mutant
(T17N). In contrast to observations in glioblastoma U251 cells, we
see no induction of macropinocytosis with a CA-Rac1 mutant
(Q61L) and conversely no protection against NGF-induced macropinocytosis in the presence of DN-Rac1 (T17N). Other small
GTPases such as Cdc42, while activated by the addition of NGF,
do not appear to be essential in the initiation of macropinocytosis
in Daoy-TrkA cells. Finally, inactivation of RhoB by phosphorylation at Ser185 by CK1 is fundamentally important in the induction of NGF-induced macropinocytosis. Inactivation of RhoB relaxes actin stress fibers and allows for actin remodeling and the
formation of membrane ruffles and lamellipodia. Conversely, activated RhoA is the final and essential GTPase that reorganizes
actin and generates the macropinosomes.
Considering the potential impact of these data, Vander Heiden
et al. have reviewed the literature and discussed the fact that exploiting the Warburg effect, the reliance of most cancer cells on
aerobic glycolysis and their need for large quantities of external
nutrients to support biomass production, has been proposed as a
general strategy to selectively kill cancer cells (87). Recently, for
example, Yun et al. have demonstrated that colorectal cancer cells
expressing K-RAS and B-RAF oncogenic mutants are selectively
sensitive to high concentrations of vitamin C due to the overexpression of a glucose transporter GLUT1 in these cells, which takes
up dehydroascorbic acid, ultimately causing accumulation of reactive oxygen species and cell death (88). Thus, the otherwise advantageous ability to take up more glucose actually makes these
cells more susceptible to cell death. Macropinocytosis is a normal
cellular process by which cells internalize extracellular fluids and
nutrients from their environment and is one strategy that Rastransformed cancer cells use to increase uptake of amino acids to
meet the needs of rapid growth (14), but we have found that nonRas-transformed medulloblastomas become susceptible to a
TrkA-driven Ras-dependent uncontrolled macropinocytosis and
tumor cell death (13). The links our studies provide here between
TrkA and the regulation of GTPases and the resulting effects on
actin cytoskeletal dynamics now provide the basis to test therapeutic strategies that target these pathways.
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